Literature DB >> 3122733

Purification and some properties of cytosolic cobalamin-binding protein in Euglena gracilis.

F Watanabe1, Y Nakano, S Kitaoka.   

Abstract

In Euglena gracilis SM-ZK, a bleached mutant of E. gracilis z, the cobalamin- (Cbl-)binding activity was distributed in cytosol (49.2%), mitochondria (20.3%) and microsomal fraction (20.4%). The cytosolic Cbl-binding activity gave two major peaks in isoelectric focusing. The Cbl-binding protein with pI 3.2 was purified 6500-fold in a yield of 19.9%, and that with pI 4.7 5800-fold in a yield of 11.9%. The monomeric Mr values of both Cbl-binding proteins were about 66,000. The Cbl-binding activity of both proteins showed a very low pH-dependency, and thiol groups and metal ions were not concerned with the Cbl-binding activities. The Ks values of the Cbl-binding proteins with pI 3.8 and 4.7 for CN-Cbl were 1.0 and 2.0 nM respectively. The Cbl-binding protein with pI 3.8 was shown to be immunologically identical with the protein with pI 4.7 by double-immunodiffusion experiments against antibody to the protein with pI 3.8. The two cytosolic Cbl-binding proteins did not show the activities of Cbl-dependent enzymes in E. gracilis, N5-methyltetrahydrofolate:homocysteine methyltransferase, methylmalonyl-CoA mutase and ribonucleotide reductase, suggesting that the two cytosolic Cbl-binding proteins play a physiological role as intracellular Cbl carriers.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3122733      PMCID: PMC1148466          DOI: 10.1042/bj2470679

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  Sites of absorption of vitamin B12.

Authors:  Y CITRIN; C DEROSA; J A HALSTED
Journal:  J Lab Clin Med       Date:  1957-11

2.  Vitamin B12 assay in body fluids using Euglena gracilis.

Authors:  G I M ROSS
Journal:  J Clin Pathol       Date:  1952-08       Impact factor: 3.411

3.  Isolation of gastric vitamin B 12 -binding proteins using affinity chromatography. I. Purification and properties of human intrinsic factor.

Authors:  R H Allen; C S Mehlman
Journal:  J Biol Chem       Date:  1973-05-25       Impact factor: 5.157

4.  One-millionfold purification of transcobalamin II from human plasma.

Authors:  L Puutula; R Gräsbeck
Journal:  Biochim Biophys Acta       Date:  1972-05-18

5.  Propanediol dehydratase system. Role of monovalent cations in binding of vitamin B 12 coenzyme or its analogs to apoenzyme.

Authors:  T Toraya; Y Sugimoto; Y Tamao; S Shimizu; S Fukui
Journal:  Biochemistry       Date:  1971-08-31       Impact factor: 3.162

6.  Nature of vitamin B 12 binding. II. Steric orientation of vitamin B 12 on binding and number of combining sites of human intrinsic factor and the transcobalamins.

Authors:  E Hippe; E Haber; H Olesen
Journal:  Biochim Biophys Acta       Date:  1971-07-25

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Microheterogeneity of the complex between human intrinsic factor and cyanocobalamin demonstrated by isoelectric focusing.

Authors:  R Gräsbeck
Journal:  Acta Chem Scand       Date:  1968

9.  Release of vitamin B-12 in vitro from intrinsic factor-vitamin B-12 complex. Purification and characterization of a releasing factor from rat ileal brush border.

Authors:  S V Khadapkar; U K Vakil
Journal:  Biochim Biophys Acta       Date:  1982-12-17

10.  Binding and uptake of transcobalamin II by human fibroblasts.

Authors:  P Youngdahl-Turner; L E Rosenberg; R H Allen
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

View more
  1 in total

1.  Identification of the gene responsible for the cblA complementation group of vitamin B12-responsive methylmalonic acidemia based on analysis of prokaryotic gene arrangements.

Authors:  C Melissa Dobson; Timothy Wai; Daniel Leclerc; Aaron Wilson; Xuchu Wu; Carole Doré; Thomas Hudson; David S Rosenblatt; Roy A Gravel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-15       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.